Agency / Source: SCHOTT North America

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SCHOTT Pharma Launches New Vials for MRNA and Gene Therapy - SCHOTT Pharma, a pioneer in pharmaceutical drug containment solutions and delivery systems, is introducing glass vials optimized for deep-cold storage of drugs - SCHOTT-Pharma.com
SCHOTT Pharma Launches New Vials for MRNA and Gene Therapy

 

PRZOOM - /newswire/ - Mainz, Rhineland-Palatinate, Germany, 2024/01/24 - SCHOTT Pharma, a pioneer in pharmaceutical drug containment solutions and delivery systems, is introducing glass vials optimized for deep-cold storage of drugs - SCHOTT-Pharma.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Manufacturing / Robotics Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• EVERIC® freeze vials withstand storage temperatures down to -80°C needed for vaccines, such as gene therapy and mRNA drugs.
• These deep-cold temperature drugs can be used to treat infectious diseases, cancer, and central nervous system disorders a growing market, which includes, for example, 11 mRNA drugs and 10 gene therapy drugs commercially available in 2023, and over 100 mRNA and 45 gene therapy drugs in clinical trials (Source: GlobalData).
• New vials prevent loss of life-saving medications and costly downtimes thanks to strength-optimized geometry leading to reduced risk of breakage.

These life-saving vaccines, such as gene therapy and mRNA medications must be frozen and transported at temperatures down to -80°C. Due to the high thermal stress and other factors in the freezing and thawing process, conventional vials are prone to glass breakage during the process, which results in costly downtimes and drug loss. To prevent this, SCHOTT Pharma’s EVERIC® freeze vials feature improved strength thanks to optimized glass tubing, vial geometry and production process. “Our scientific strength tests have shown that the new vials outperform standard vials, making them a dedicated solution for frozen medications used to treat infectious diseases, cancer, and central nervous system disorders,” said Andreas Reisse, CEO of SCHOTT Pharma.

In 2023, there were for example 11 mRNA drugs and 10 gene therapy drugs commercially available, which required deep-cold storage, and over 100 mRNA and 45 gene therapy drugs in clinical trials (Source: GlobalData). Pharma companies are therefore looking for an experienced partner in terms of drug containment and delivery systems, who can provide the right solution to help shorten the time to market. “By expanding our portfolio with the new vials, we are now the only partner to leading pharma companies, who can offer both polymer and glass solutions for deep-cold storage requirements,” adds Reisse.

On top, drug manufacturers want to ensure that the drug remains stable until it reaches the patient. For this, the container closure integrity (CCI) is crucial. However, it, too, is at risk in deep-cold temperatures because the stoppers can shrink and lose elasticity, which could affect the drug’s efficacy. Through vigorous scientific testing with eight variants, SCHOTT Pharma found a 0% failure rate for all configurations, showing that CCI can be maintained for all combinations within ISO dimensions, including EVERIC® freeze vials.

The new vials are manufactured in Müllheim, Germany, which is also where SCHOTT Pharma’s competence center is located, can be supplied as ready-to-use (RTU) if requested and are available in 2 30 mL. The solution is the newest member of the established EVERIC® portfolio, which allows pharma companies to flexibly combine features to address different needs and enhance efficiency.

About SCHOTT Pharma

SCHOTT Pharma (schott-pharma.com) designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world because human health matters. The portfolio comprises drug containment solutions and delivery systems for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of around 4,700 people from over 65 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house, a state-of-the-art R&D center in Switzerland, the company is focused on developing innovations for the future. SCHOTT Pharma AG & Co. KGaA, headquartered in Mainz, Germany, is part of SCHOTT AG that is fully owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030. Currently, SCHOTT Pharma has over 1,800 customers including the top 30 leading pharma manufacturers for injectable drugs and generated revenues of EUR 821 million in the fiscal year 2022.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Manufacturing / Robotics Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: SCHOTT North America

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Manufacturing / Robotics articles,
CATCH Visitors via Your Competitors Announcements!


SCHOTT Pharma Launches New Vials for MRNA and Gene Therapy

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
EVERIC® Freeze | SCHOTT Pharma
Contact: Joana Kornblum - SCHOTT.com 
joana.kornblum[.]schott.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SCHOTT North America securities in any jurisdiction including any other companies listed or named in this release.

Manufacturing / Robotics via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From SCHOTT North America / Company Profile


Read Manufacturing / Robotics Most Recent Related Press Releases:

LANXESS to Showcase Comprehensive Portfolio for Battery Production
SCHOTT Pharma Opens State-of-the-Art Production Facility in Lukácsháza, Hungary
TRUMPF Presents Live Showcases of Cutting-edge VCSEL Solutions for Optical Sensing At SENSOR+TEST
BASF Accelerates its Plastics Journey At Plastics Recycling Show Europe 2024
ABB Transforms Flow Measurement in the Field with Ethernet-APL Connectivity
ABB Launches Next-generation Robotics Control Platform OmniCore
BASF Sells Bioenergy Enzymes Business to Lallemand
TDK Launches Environmentally Sustainable Radio Wave Absorbers Using Biomass Material
Bekaert Strengthens its Offering in Synthetic Offshore Lifting and Mooring Solutions Via the Acquisition of BEXCO
LANXESS to Exhibit its Extensive Portfolio of Aroma Chemicals for the First Time At SIMPPAR Perfumery Ingredients Trade Fair

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today